The Latest Breaking News from FDA

A new non-opioid painkiller, suzetrigine, has just been approved by the US drug regulator, the FDA. It is the first non-opioid painkiller the agency has approved in over two decades.

China, one of the countries affected by the new tariffs, is the world’s largest producer of active pharmaceutical ingredients.

AMGN stock is down over 1% despite beating revenue and earnings estimates; investors are selling the news on the company’s latest obesity drug and weak guidance

The products were sold throughout nine states and online

With the rapid integration of technology into healthcare, the need for robust cybersecurity measures has become a non-negotiable. Medical devices, which increasingly rely on software and connectivity, bring unprecedented convenience and improved ...

Breadcrumbs sold by La Fiesta Food Products are being recalled by the company for presence of an undeclared allergen. The company has announced the voluntary recall of its 8-ounce packages of "Unseasoned Bread Crumbs" and "Seasoned Bread Crumbs" due to the presence of undeclared sesame, a potential allergen.

Taking a compounded GLP-1 medication isn’t the same thing as your pharmacy filling a cheaper, generic version of the drug your doctor prescribed.

The recalled baby teething product was sold in 45 states

There is a "warning of potentially serious or even deadly consequences from consuming the product"

The CISA and FDA have released security warnings about the Contec CMS8000, which is used for patient monitoring.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.